Cover
Cover | 3 Months Ended |
Jul. 31, 2024 shares | |
Cover [Abstract] | |
Document Type | 10-Q |
Amendment Flag | false |
Document Quarterly Report | true |
Document Transition Report | false |
Document Period End Date | Jul. 31, 2024 |
Document Fiscal Period Focus | Q1 |
Document Fiscal Year Focus | 2025 |
Current Fiscal Year End Date | --04-30 |
Entity File Number | 333-257326 |
Entity Registrant Name | ORION BLISS CORP. |
Entity Central Index Key | 0001854183 |
Entity Tax Identification Number | 98-1591444 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | Kalonite 9-57 |
Entity Address, City or Town | Ashdod |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 7724233 |
City Area Code | 307 |
Local Phone Number | 298 0969 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |
Entity Shell Company | true |
Entity Common Stock, Shares Outstanding | 3,038,000 |
Balance Sheets
Balance Sheets - USD ($) | Jul. 31, 2024 | Apr. 30, 2024 |
Current Assets | ||
Escrow Account | $ 740 | $ 1,190 |
Total Current Assets | 740 | 1,190 |
Website Development, net | 134 | 134 |
Total Assets | 874 | 1,324 |
Current Liabilities | ||
Accounts payable - Related party | 40,000 | 37,000 |
Director loan | 63,572 | 53,517 |
Total Current Liabilities | 103,572 | 90,517 |
Stockholders’ Deficit | ||
Common stock, par value $0.0001; 75,000,000 shares authorized, 3,038,000 shares issued and outstanding respectively; | 304 | 304 |
Additional paid-in capital | 20,656 | 20,656 |
Accumulated deficit | (123,658) | (110,153) |
Total Stockholders’ Deficit | (102,698) | (89,193) |
Total Liabilities and Stockholders’ Deficit | $ 874 | $ 1,324 |
Balance Sheets (Parenthetical)
Balance Sheets (Parenthetical) - $ / shares | Jul. 31, 2024 | Apr. 30, 2024 |
Statement of Financial Position [Abstract] | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 75,000,000 | 75,000,000 |
Common Stock, Shares, Issued | 3,038,000 | 3,038,000 |
Common Stock, Shares, Outstanding | 3,038,000 | 3,038,000 |
STATEMENT OF OPERATIONS (Unaudi
STATEMENT OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Income Statement [Abstract] | ||
REVENUES (Consulting services) | $ 0 | $ 0 |
General and Administrative Expenses | 13,505 | 33,623 |
NET INCOME (LOSS) FROM OPERATION | (13,505) | (33,623) |
PROVISION FOR TAXES | 0 | 0 |
NET INCOME (LOSS) | $ (13,505) | $ (33,623) |
STATEMENT OF OPERATIONS (Unau_2
STATEMENT OF OPERATIONS (Unaudited) (Parenthetical) - $ / shares | 3 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Income Statement [Abstract] | ||
Earnings Per Share, Basic | $ 0 | $ 0 |
Earnings Per Share, Diluted | $ 0 | $ 0 |
Weighted Average Number of Shares Outstanding, Basic | 3,038,000 | 3,038,000 |
Weighted Average Number of Shares Outstanding, Diluted | 3,038,000 | 3,038,000 |
STATEMENTS OF STOCKHOLDER EQUIT
STATEMENTS OF STOCKHOLDER EQUITY (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Mar. 22, 2021 | $ 0 | $ 0 | $ 0 | $ 0 |
Shares, Outstanding, Beginning Balance at Mar. 22, 2021 | 0 | |||
Shares issued for cash at $0.02 per share during July, October and January. | $ 200 | 200 | ||
Stock Issued During Period, Shares, New Issues | 2,000,000 | |||
Net loss | (1,925) | (1,925) | ||
Ending balance, value at Apr. 30, 2021 | $ 200 | 0 | (1,925) | (1,725) |
Shares, Outstanding, Ending Balance at Apr. 30, 2021 | 2,000,000 | |||
Net loss | (26,690) | (26,690) | ||
Ending balance, value at Apr. 30, 2022 | $ 200 | 0 | (28,615) | (28,415) |
Shares, Outstanding, Ending Balance at Apr. 30, 2022 | 2,000,000 | |||
Shares issued for cash at $0.02 per share during July, October and January. | $ 104 | 20,656 | 20,760 | |
Stock Issued During Period, Shares, New Issues | 1,038,000 | |||
Net loss | (29,182) | (29,182) | ||
Ending balance, value at Apr. 30, 2023 | $ 304 | 20,656 | (57,797) | (36,837) |
Shares, Outstanding, Ending Balance at Apr. 30, 2023 | 3,038,000 | |||
Net loss | (52,356) | (52,356) | ||
Ending balance, value at Apr. 30, 2024 | $ 304 | 20,656 | (110,153) | (89,193) |
Shares, Outstanding, Ending Balance at Apr. 30, 2024 | 3,038,000 | |||
Net loss | (13,505) | (13,505) | ||
Ending balance, value at Jul. 31, 2024 | $ 304 | $ 20,656 | $ (123,658) | $ (102,698) |
Shares, Outstanding, Ending Balance at Jul. 31, 2024 | 3,038,000 |
STATEMENT OF CASH FLOWS (Unaudi
STATEMENT OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Apr. 30, 2024 | Apr. 30, 2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income (loss) for the period | $ (13,505) | $ (33,623) | $ (52,356) | $ (29,182) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Website Development | 0 | 0 | ||
Changes in assets and liabilities: | ||||
CASH FLOWS USED IN OPERATING ACTIVITIES | (13,505) | (33,623) | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Proceeds from issuing common stock at $0.02 per share | 0 | 0 | ||
Accounts Payable - Related Party | 3,000 | 3,000 | ||
Related Party loans | 10,055 | 23,173 | ||
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES | 13,055 | 26,173 | ||
Net Cash Increase (Decrease) for Period | (450) | (7,450) | ||
Cash at the beginning of Period | 1,190 | 7,781 | 7,781 | |
Cash at end of Period | 740 | 331 | $ 1,190 | $ 7,781 |
SUPPLEMENTAL CASH FLOW INFORMATION: | ||||
Interest paid | 0 | 0 | ||
Income taxes paid | $ 0 | $ 0 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
Apr. 30, 2021 | Jul. 31, 2024 | Jul. 31, 2023 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Pay vs Performance Disclosure [Table] | ||||||
Net Income (Loss) | $ (1,925) | $ (13,505) | $ (33,623) | $ (52,356) | $ (29,182) | $ (26,690) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jul. 31, 2024 | |
Trading Arrangements, by Individual [Table] | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
ORGANIZATION AND NATURE OF BUSI
ORGANIZATION AND NATURE OF BUSINESS | 3 Months Ended |
Jul. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND NATURE OF BUSINESS | Note 1 – ORGANIZATION AND NATURE OF BUSINESS Orion Bliss Corp. (referred as the “Company”, “we”, “our”) was Incorporated in the State of Nevada and established on March 23, 2021. We are a development-stage company formed to commence operations related to selling Milk_shake hairline products. We have website which is being developed at http://orionbliss.co.il. Our office is located at Kalonite 9-57, Ashdod, Israel, zip code 7724233. |
GOING CONCERN
GOING CONCERN | 3 Months Ended |
Jul. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
GOING CONCERN | Note 2 – GOING CONCERN The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern. The Company has an accumulated deficit of $ 123,658 110,153 |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Jul. 31, 2024 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three -months ended July 31, 2024, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2024. These unaudited condensed financial statements should be read in conjunction with the April 30, 2024, financial statements and notes thereto. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Deferred Offering Costs Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, Other Assets and Deferred Costs Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value. For the three levels are defined as follows: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at July 31, 2024. Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Long-Lived Assets – Intangible Assets We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred. Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of July 31, 2024, there were no Recent Accounting Pronouncements We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company. Risks and Uncertainties In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications. |
COMMON STOCK
COMMON STOCK | 3 Months Ended |
Jul. 31, 2024 | |
Equity [Abstract] | |
COMMON STOCK | Note 4 – COMMON STOCK The Company has 75,000,000 0.0001 On April 15, 2022 the Company issued 2,000,000 200 In July, 2023, the Company issued 65,500 1,310 In September and January 2023, the Company issued 822,500 16,450 In November and December 2022 followed by January 2023, the Company issued 150,000 3,000 There were 3,038,000 Voting Common Stock All shares of common stock have voting rights and are identical. All holders of shares of voting common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder. Non-voting Common Stock All of the other terms of the Non-Voting Common Stock shall be identical to the Voting Common Stock, except for the right of first refusal that attaches to the Non-Voting Common Stock, as explained in the Company’s Bylaws. |
INCOME TAXES
INCOME TAXES | 3 Months Ended |
Jul. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | Note 5 – INCOME TAXES On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. The reconciliation of income tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows: Schedule of income tax benefit (expense) July 31, 2024 Tax benefit (expenses) at U.S. statutory rate $ (2,836 ) Change in valuation allowance 2,836 Tax benefit (expenses), net $ – The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows: Schedule of deferred taxes July 31, 2024 Net operating loss $ (25,968 ) Valuation allowance 25,968 Deferred tax assets, net $ – The Company has accumulated approximately $ 123,658 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Jul. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | Note 6 – COMMITMENTS AND CONTINGENCIES Our sole officer and director, Alexandra Solomovskaya, has agreed to provide her own premise under office needs. She will not take any fee for these premises it is for free use. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Jul. 31, 2024 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | Note 7 – SUBSEQUENT EVENTS In accordance with ASC 855-10 the Company has analyzed its operations subsequent to July 31, 2024 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Jul. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three -months ended July 31, 2024, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2024. These unaudited condensed financial statements should be read in conjunction with the April 30, 2024, financial statements and notes thereto. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Deferred Offering Costs | Deferred Offering Costs Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, Other Assets and Deferred Costs |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value. For the three levels are defined as follows: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at July 31, 2024. |
Income Taxes | Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. |
Long-Lived Assets – Intangible Assets | Long-Lived Assets – Intangible Assets We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred. |
Basic Income (Loss) Per Share | Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of July 31, 2024, there were no |
Recent Accounting Pronouncements | Recent Accounting Pronouncements We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company. |
Risks and Uncertainties | Risks and Uncertainties In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. |
Financial Statement Reclassification | Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications. |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 3 Months Ended |
Jul. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Schedule of income tax benefit (expense) | Schedule of income tax benefit (expense) July 31, 2024 Tax benefit (expenses) at U.S. statutory rate $ (2,836 ) Change in valuation allowance 2,836 Tax benefit (expenses), net $ – |
Schedule of deferred taxes | Schedule of deferred taxes July 31, 2024 Net operating loss $ (25,968 ) Valuation allowance 25,968 Deferred tax assets, net $ – |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) - USD ($) | Jul. 31, 2024 | Apr. 30, 2024 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Retained Earnings (Accumulated Deficit) | $ 123,658 | $ 110,153 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares | 3 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Accounting Policies [Abstract] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 0 |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 5 Months Ended | ||||
Apr. 15, 2022 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | Jan. 31, 2023 | Jan. 31, 2023 | Apr. 30, 2024 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
Common Stock, Shares Authorized | 75,000,000 | 75,000,000 | |||||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | |||||
Proceeds from the sale of stock | $ 0 | $ 0 | |||||
Common Stock, Shares, Issued | 3,038,000 | 3,038,000 | |||||
Common Stock, Shares, Outstanding | 3,038,000 | 3,038,000 | |||||
Director [Member] | |||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
Stock issued for services, shares | 2,000,000 | ||||||
Stock issued for services, value | $ 200 | ||||||
Three Shareholders [Member] | |||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
Stock issued new, shares | 65,500 | ||||||
Proceeds from the sale of stock | $ 1,310 | ||||||
Twenty Nine Shareholders [Member] | |||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
Stock issued new, shares | 822,500 | ||||||
Proceeds from the sale of stock | $ 16,450 | ||||||
Five Shareholders [Member] | |||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
Stock issued new, shares | 150,000 | ||||||
Proceeds from the sale of stock | $ 3,000 |
INCOME TAXES (Details - Income
INCOME TAXES (Details - Income tax expense) - USD ($) | 3 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||
Tax benefit (expenses) at U.S. statutory rate | $ (2,836) | |
Change in valuation allowance | 2,836 | |
Tax benefit (expenses), net | $ 0 | $ 0 |
INCOME TAXES (Details - Deferre
INCOME TAXES (Details - Deferred taxes) | Jul. 31, 2024 USD ($) |
Income Tax Disclosure [Abstract] | |
Net operating loss | $ (25,968) |
Valuation allowance | 25,968 |
Deferred tax assets, net | $ 0 |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) | Jul. 31, 2024 USD ($) |
Income Tax Disclosure [Abstract] | |
Operating Loss Carryforwards | $ 123,658 |